Global Veterinary Drug Market Growth 2021-2026

According to this latest study, the 2021 growth of Veterinary Drug will have significant change from previous year. By the most conservative estimates of global Veterinary Drug market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ 21690 million in 2020. Over the next five years the Veterinary Drug market will register a 5.7% CAGR in terms of revenue, the global market size will reach US$ 27120 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Pets
Cattle
Poultry
Swine
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur